Clinical Trials Browser

Phase 2 × Leukemia, Biphenotypic, Acute × decitabine and cedazuridine drug combination × Clear all

NCT04975919 2026-05-14

Venetoclax in Combination With Decitabine and Cedazuridine for the Treatment of Relapsed or Refractory Acute Myeloid Leukemia

Phase 2 Active not recruiting

Other hematologic neoplasm

Leukemia, Biphenotypic, Acute, Leukemia, Myeloid, Acute